Shopping Cart

No products in the cart.

Welcome To

ISPOR 2025 United Arab Emirates Chapter Conference

Join HEOR leaders, policymakers, and innovators at the first-ever ISPOR UAE Chapter conference!

5
4
3
2
1
23

50+

Speakers

Welcome To

ISPOR 2025 United Arab Emirates Chapter Conference

Join HEOR leaders, policymakers, and innovators at the first-ever ISPOR UAE Chapter conference!

5
4
3
2
1
23

50+

Speakers

Event Location

Rosewood Hotel Abu Dhabi

Event Time

23-24 May, 2025

Welcome Message

We are delighted to welcome you to join us at the ISPOR 2025 United Arab Emirates Chapter Conference, taking place at Rosewood Hotel, Abu Dhabi, on May 23-24, 2025.

Our must-attend event offers a dynamic program featuring esteemed keynote speakers, engaging discussions, and insightful scientific poster presentations.

We hope you find the conference both inspiring and valuable, fostering meaningful connections with peers and industry leaders while sparking innovative ideas.

We look forward to your participation!

Best regards,

Professor Nadia Al Mazrouei,

ISPOR UAE Chapter President Assoc. Professor in Sharjah University Abu Dhabi Emirate, United Arab Emirates

Objectives:

  • 23
    Advancing Patient-Centered Healthcare: Promote discussions on value-based care to deliver patient-centered outcomes and integrate the perspectives of patients and stakeholders in HEOR discussions to ensure equitable and efficient healthcare solutions.
  • 23
    Empowering Local Expertise for Global Impact: Showcase the contributions of UAE-based HEOR experts in shaping regional and international healthcare strategies and encourage capacity building and knowledge sharing to empower local professionals, fostering a thriving HEOR community.
  • 23
    Bridging Research and Practice in a Digital Era: Highlight advancements in digital health technologies, such as AI and data analytics, to bridge the gap between HEOR research and real-world applications and facilitate discussions on the integration of digital tools to enhance patient outcomes and optimize healthcare costs in the UAE and globally.

ISPOR 2025 United Arab Emirates Chapter Conference

Book Your Place Now

Don’t miss out on the FREE Extra Discount for members! 🎁

850.00 AED – 2,250.00 AED

Book Ticket
View Description

850.00 AED – 2,250.00 AED

Book Ticket
View Description

850.00 AED – 2,250.00 AED

Book Ticket
View Description

Free Limited Seats Available

Book Ticket
View Description

1,400.00 AED – 2,900.00 AED

Book Ticket

850.00 AED – 2,250.00 AED

Book Ticket
View Description

850.00 AED – 2,250.00 AED

Book Ticket
View Description

850.00 AED – 2,250.00 AED

Book Ticket
View Description

Free Limited Seats Available

Book Ticket
View Description

1,400.00 AED – 2,900.00 AED

Book Ticket

Meet our Speakers:

The ISPOR 2025 United Arab Emirates Chapter Conference brings together a distinguished line-up of speakers, each offering exceptional expertise to inspire impactful discussions and drive innovation in the field of Health Economics & Outcomes Research (HEOR)

Picture8
Dr. Abeer Al-Rabayah
Speaker

Head of Pharmacy at King Hussein Cancer Center (KHCC), Jordan

Picture9
Dr. Anas Hamad
Speaker

Director of Pharmacy & Head of Medication Safety/Quality at Hamad Medical Corporation, Clinical Associate Professor at Qatar University

IMG_0274
Dr. Alexandr Kostyuk
Speaker

Advisor to the Minister of Health Republic of Kazakhstan

Picture5
Dr. Asmaa Saad
Speaker

Head of Pharmacoeconomics Unit, Egyptian Drug Authority

Picture2
Prof. Daoud Al-badriyeh
Speaker

Professor of Pharmacoeconomics and Outcomes Research at Qatar University

Picture7
Dr. Mouna Jameleddine
Speaker

Director of the HTA and economic evaluation Department-INEAS- WHO Expert, Tunisia Vice-Chair of INAHTA (the International Network of Agencies for HTA)

Picture6
Prof. Hussain Al-Omar
Speaker

Consultant & Associate Professor, Clinical Pharmacy Department, Director, Health Technology Assessment Unit, King Saud University

Picture1
Prof. Ibrahim Al-abbadi
Speaker

Professor of Pharmacoeconomics and Pharmaceutical Marketing - The University of Jordan

Picture3
Dr. Tomasz Kluszczynski
Speaker

Professor at Warsaw University of Technology and Goethe Frankfurt University

Picture11
Dr. Wadih Mina
Speaker

President-Elect of the ISPOR Lebanon Chapter, Health Economics and Market Access Lead at Boston Scientific

Picture4
Prof. Zaheer-Ud-Din Babar
Speaker

Professor of Clinical Pharmacy and Practice - Qatar University, Consultant on Pharmaceutical Pricing

Agenda:

Shaping the Future of Health Economics & Outcomes Research: A Visionary Agenda at the ISPOR UAE Chapter 2025 Conference

Scientific Committee:

Meet the esteemed Scientific committee behind the conference!

ABSTRACT SUBMISSION

The ISPOR 2025 United Arab Emirates Chapter conference is a platform for transformative discussions in Health Economics & Outcomes Research (HEOR). Seize this opportunity to showcase your ground-breaking research and contribute to the global HEOR community!

Why to Submit an Abstract?

  • Connect with thousands of researchers, regulators, payers, and thought leaders
  • Contribute your innovative ideas, and novel knowledge to advance the science of HEOR.
  • Gain global recognition and widespread dissemination of your work.

Submit an Abstract:

Submission period: 1st of March 2025 – 20th of May 2025.

You must book the International ISPOR UAE Chapter Conference 2025 to submit an abstract. Book now.
Welcome Registration Speakers Agenda Committee Abstract Sponsors
subscription

Quick Links

Contact Us

Linkedin

Copyright © 2025 - Stellar Consulting MEA

ROUND TABLE DISCUSSION (1)

Equitable Access to Innovative Medications

Description:

This roundtable, led by the Department of Health (DOH) - Abu Dhabi, will explore strategies to improve equitable access to high-cost innovative medications in the UAE. The session will address key barriers such as pricing, reimbursement, and HTA frameworks, and feature insights from NICE International’s value-based approaches and the UK's Voluntary Scheme for Branded Medicines Pricing and Access (VPAG). Regional and international case studies will highlight practical solutions, with key outcomes synthesized into a white paper to guide future access strategies.

What you will learn:

  • How Health Technology Assessment (HTA) frameworks can be adapted to support timely and equitable access to innovative medications in the UAE.
  • Strategies for designing pricing and reimbursement policies that promote both pharmaceutical innovation and healthcare system sustainability.
  • The role of real-world evidence in informing HTA decisions and shaping access policies for innovative therapies.
  • Collaborative approaches to strengthen alignment and communication between regulatory authorities, payers, and the pharmaceutical industry.
  • Key insights from international and regional case studies on improving access to rare disease and oncology treatments.
ROUND TABLE DISCUSSION (2)

Shaping The Future of Medicine Pricing in the UAE: Policy Innovation and the Transition to Value-Based Pricing

Description:

This strategic roundtable will explore the UAE’s evolving approach to pharmaceutical pricing in alignment with its healthcare innovation agenda. The session will examine how the UAE can adapt its External Reference Pricing (ERP) system to support a future-ready, value-based pricing (VBP) model.

What you will learn:

  • Strengths and current structure of the UAE's ERP system.
  • Opportunities for proactively evolving ERP toward value-based care.
  • Strategic alignment between ERP and VBP to support innovation and access.
  • Frameworks for developing a UAE-specific VBP model.
  • Practical steps toward positioning the UAE as a regional leader in VBP implementation.
WORKSHOP (3)

Closing the Value Gaps: Time for fit-for-purpose HTA for MedTech in MEA region

Description:

This workshop will explore why traditional HTA frameworks fall short for medical devices and in-vitro diagnostics (IVDs) and unpack the fundamental differences between MedTech and pharmaceuticals, examining real-world performance, iterative design, and system-wide value.

What you will learn:

  • Key differences between evaluating pharmaceuticals and medical devices/IVDs.
  • International best practices for assessing medical technologies.
  • Considerations for developing a regionally relevant HTA framework for MedTech.
  • Strategies to ensure timely and equitable access to high-value devices and diagnostics in MEA.
  • The role of multi-stakeholder collaboration (regulators, providers, industry, academia) in shaping future MedTech assessments.
PANELS DISCUSSION

Biosimilars Gulf Forum

Description:

The panel will discuss the health economics and outcomes research (HEOR) landscape for biosimilars in the UAE and GCC, focusing on cost savings, therapeutic equivalence, and barriers to adoption. Interactive sessions will highlight real-world evidence (RWE) from chronic disease management, explore payer and provider perspectives on switching protocols and patient education, and propose policy recommendations to accelerate biosimilar uptake across the region.

What you will learn:

  • Real-world evidence (RWE) on biosimilar performance in chronic diseases such as diabetes and rheumatology.
  • Key payer and provider perspectives on switching protocols and strategies for patient education.
  • Policy recommendations to support and accelerate biosimilar adoption in the region.
  • Challenges and opportunities in the current HEOR landscape for biosimilars.